Finding · criterion S3

How many peptide sellers name the pharmacy that fills the order?

244 of the 586 sellers in the ledger name the pharmacy that fills the order. 331 do not. 11 records carry a null, because the seller has no storefront left to check.

Criterion S3, pharmacy identification, asks for a name that identifies a real facility. A category is not a name. The census below was run against Standard v1.1, on the date stated above, over every record in the ledger, and the full roster sits at the foot of this page so the count can be repeated.

The number, with both denominators

Of the 586 sellers recorded, 244 satisfy S3 and 331 fail it. 11 sellers are excluded from the numerator and named here rather than counted: Chemyo, Peptide Sciences, Polaris Peptides, Regen Peptides, Rivo Health, Science Bio, SuperHealthy Rx, TD Tele-Doc Weight Loss, TeleWellnessMD, TideMedix, Xcel Peptides. Against the adjusted denominator of 575 checked sellers, the count is still 244.

The split by kind is sharper than the total. Among the 536 telehealth services, 244 name a filling pharmacy and 287 do not. Among the 50 research vendors, none names one, 44 fail it, and 6 carry a null.

What stands in place of a name

The two kinds fail S3 differently, and the difference matters. A failing telehealth record substitutes a legal category for a facility. The failing research vendors do not divide so neatly, and the roster at the foot of this page shows why. Some state that no pharmacy is involved at all: Biotech Peptides says in its footer that it is neither a compounding pharmacy under 503A nor an outsourcing facility under 503B. Others record only that no facility is named on the pages read, which is a narrower fact. Two of them say something different again, disclaiming fulfillment and assigning it to third parties they do not name, which is neither a claim that a pharmacy is involved nor a claim that none is. Each record's own basis says which of the three it is, and this page does not flatten them into one reason. Four of the telehealth phrases were read first-hand and are quoted verbatim below.

All four quotations below were read August 2026.

Two of those four invoke section 503A of the Federal Food, Drug, and Cosmetic Act by number. Section 503A is a legal category that thousands of pharmacies occupy, and citing it identifies no facility, no license, and no state. The other two name a country or a state instead. None of the four is a name a reader can carry to a state board of pharmacy.

MangoRx is the record where placement decides the answer. Its frequently asked questions describe “a Texas-based compounding pharmacy” and name nothing, while its terms and conditions name Epiq Scripts, LLC as the pharmacy providing fulfillment. S3 is checked against terms as well as marketing pages, so the record passes, and a reader who stops at the FAQ learns less than a reader who opens the terms.

What the sellers who name a pharmacy actually publish

Disclosure at the passing end is not minimal. He & She MD prints a pharmacy name, a street address and a telephone number. Embody prints four pharmacies with street addresses and telephone numbers. Eden names four partner pharmacies with street addresses. Ro names its own pharmacy and three licensed locations, and does not name the compounding partners that make its compounded products. Care Bare Rx and Synergy Rx each print four pharmacy names.

The same facility recurs. Epiq Scripts is named in 26 of the 586 records in the ledger: Ascend Vitality, Avono Health, Bodybuilding Health+, Breeze Meds, Care Bare Rx, Dr. Arevitalize, ElleS, EverSlim, Fitness RX, Heros Health, MangoRx, OnlyRx, Pallas Health, Peak Wellness, Raeliva, Remote Pharmacy, RENN Health, Revive Meds, RxSpan MD, Sunlight, Synergy Rx, Teleios Health, Tell Her Doc, Trimrose, Vea Health, Willow. Naming a shared facility is a disclosure, not a defect, and it is the only reason the overlap is visible at all.

Why the question is not decorative

A named pharmacy can be looked up in a state board register, checked for licensure, and read against inspection history. A category cannot. In February 2026 the Food and Drug Administration wrote to Strut Health, LLC about exactly this gap, stating that its website labeling suggested it compounded its own products when it did not, and asking it to identify the entities that produce the compounded products offered on its website. The letter alleges and does not adjudicate, it did not halt the business, and the seller still trades. It is recorded and dated on the Strut Health record under S8, which fails a seller only where an action stopped it operating.

The full roster

Every seller counted above, with its S3 disposition and the basis recorded against it on the date stated above. Dispositions render in three states, and NOT VERIFIED is a null that counts neither way.

Sources

All 9 sources below read August 2026.

• HealthRX home page and footer
• Found, compounded semaglutide page
• Strut Health, Our Story
• MangoRx, frequently asked questions
• MangoRx, terms and conditions
• He & She MD, pharmacy partners
• Embody, partner pharmacies
• FDA warning letter 721448 to Strut Health, LLC dba Strut, February 20, 2026
• Federal Food, Drug, and Cosmetic Act, section 503A

Counts are generated from the ledger at build time, so this page cannot drift from the records it summarizes. Method and null semantics: how checks are performed. This page ranks nothing, recommends nothing, and carries no partner link.

Related findings

All 32 findings →